Latin America Eubiotics Market Size & Outlook, 2022-2030
Related Markets
Latin America eubiotics market highlights
- The Latin America eubiotics market generated a revenue of USD 114.1 million in 2022.
- The market is expected to grow at a CAGR of 6.4% from 2023 to 2030.
- In terms of segment, probiotics was the largest revenue generating product in 2022.
- Probiotics is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, Argentina is expected to register the highest CAGR from 2023 to 2030.
Latin America data book summary
| Market revenue in 2022 | USD 114.1 million |
| Market revenue in 2030 | USD 187.2 million |
| Growth rate | 6.4% (CAGR from 2022 to 2030) |
| Largest segment | Probiotics |
| Fastest growing segment | Probiotics |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Probiotics, Prebiotics, Organic Acids, Phtyogenics |
| Key market players worldwide | DSM Firmenich AG, Mitsui & Co Ltd, Lallemand, Beneo, Kemin Industries, DuPont de Nemours Inc, Novonesis AS ADR, Associated British Foods PLC, Novozymes, Evonik Industries AG, Basf SE, Cargill, Archer-Daniels Midland Co, China National Bluestar Group |
Other key industry trends
- In terms of revenue, Latin America region accounted for 2.3% of the global eubiotics market in 2022.
- Globally, Europe is projected to lead the regional market in terms of revenue in 2030.
- North America is the fastest growing regional market and is projected to reach USD 2,654.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Eubiotics Market Scope
Eubiotics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Mitsui & Co Ltd | View profile | 55874 | 1-3, Marunouchi 1-chome, Chiyoda-ku, Tokyo, Japan, 100-8631 | https://www.mitsui.com |
| Beneo | View profile | 501-1000 | Mannheim, Baden-Wurttemberg, Germany, Europe | https://www.beneo.com/ |
| Novozymes | View profile | 5001-10000 | Bagsværd, Hovedstaden, Denmark, Europe | https://www.novozymes.com/en# |
| Lallemand | View profile | 5001-10000 | Rexdale, Ontario, Canada, North America | http://www.lallemand.com |
| China National Bluestar Group | View profile | 10001+ | Beijing, Beijing, China, Asia | http://www.china-bluestar.com/ |
| Novonesis AS ADR | View profile | 6756 | Krogshoejvej 36, Bagsvaerd, Denmark, 2880 | https://www.novozymes.com |
| Kemin Industries | View profile | 1001-5000 | Des Moines, Iowa, United States, North America | http://www.kemin.com |
| Cargill | View profile | 10001+ | Minneapolis, Minnesota, United States, North America | http://www.cargill.com |
| DuPont de Nemours Inc | View profile | 24000 | 974 Centre Road, Building 730, Wilmington, DE, United States, 19805 | https://www.dupont.com |
| Archer-Daniels Midland Co | View profile | 41802 | 77 West Wacker Drive, Suite 4600, Chicago, IL, United States, 60601 | https://www.adm.com |
| DSM Firmenich AG | View profile | 30000 | Wurmisweg 576, Kaiseraugst, Switzerland, 4303 | https://www.dsm-firmenich.com/corporate/home.html |
| Associated British Foods PLC | View profile | 133000 | 10 Grosvenor Street, Weston Centre, London, United Kingdom, W1K 4QY | https://www.abf.co.uk |
| Evonik Industries AG | View profile | 33409 | Rellinghauser Strasse 1-11, Essen, NW, Germany, 45128 | https://www.evonik.com |
| Basf SE | View profile | 111855 | Carl-Bosch-Strasse 38, Ludwigshafen am Rhein, Germany, 67056 | https://www.basf.com |
Latin America eubiotics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to eubiotics market will help companies and investors design strategic landscapes.
Probiotics was the largest segment with a revenue share of 36.72% in 2022. Horizon Databook has segmented the Latin America eubiotics market based on probiotics, prebiotics, organic acids, phtyogenics covering the revenue growth of each sub-segment from 2018 to 2030.
The above chart depicts the type of meat consumed in Brazil, with beef accounting for 40% of the total consumption, followed by chicken. In addition, Brazil is one of the major producers and exporters of meat across the world.
Rising meat consumption in the country has propelled the demand for high-quality meat production, which is anticipated to drive the consumption of feed additives in livestock sector. This is expected to drive the demand for eubiotics ingredients in feed additives industry.
The country is continuously striving toward producing disease-free, high-quality meat products. Commonly occurring diseases, such as bovine spongiform encephalopathy (BSE), are a major threat to meat processors as infected meat is hazardous for human consumption.
Reasons to subscribe to Latin America eubiotics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America eubiotics market databook
-
Our clientele includes a mix of eubiotics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America eubiotics market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America eubiotics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America eubiotics market size, by country, 2018-2030 (US$M)
Latin America Eubiotics Market Outlook Share, 2022 & 2030 (US$M)
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
